Abstract:Purpose: Microorganisms contribute to the pathogenesis of obstructive sleep apnea (OSA)-associated hypertension (HTN), while more studies focus on intestinal microbiome. However, the relationship between oral microbiota and OSA-associated HTN has yet to be elucidated. This study aimed to identify differences in salivary microbiota between patients with OSA comorbid HTN compared with OSA patients, and furthermore evaluate the relationship between oral microbiome changes and increased blood pressure in patients with OSA. Patients and Methods: This study collected salivary samples from 103 participants, including 27 healthy controls, 27 patients with OSA, 23 patients with HTN, and 26 patients with OSA comorbid HTN, to explore alterations of the oral microbiome using 16S rRNA gene V3-V4 high-throughput sequencing. And ultra-high-performance liquid chromatography was used for metabolomic analysis. Results: Alpha- and beta-diversity analyses revealed a substantial difference in community structure and diversity in patients with OSA comorbid HTN compared with patients with OSA or HTN. The relative abundance of the genus Actinomyces was significantly decreased in patients with HTN compared with healthy controls, and those with OSA concomitant HTN compared with the patients in OSA, but was not significantly different between patients with OSA and healthy controls. Linear discriminant analysis effect size and variance analysis also indicated that the genera Haemophilus, Neisseria, and Lautropia were enriched in HTN. In addition, Oribacterium was an unique taxa in the OSA comorbid HTN group compared with the control group. Metabolomic analysis of saliva identified compounds associated with cardiovascular disease in patients with OSA comorbid HTN.2-hydroxyadenine, was significantly increased in the group of patients with OSA compared with controls, and L-carnitine was significantly decreased in patients with OSA comorbid HTN compared with OSA patients. Conclusion: This study highlighted noninvasive biomarkers for patients with OSA comorbid HTN. As the first study to find alterations of the salivary microbiome in patients with OSA comorbid HTN, it may provide a theoretical foundation for clinical diagnosis and treatment of this condition.

Circulating C3 and Glucose Metabolism Abnormalities in Patients with OSAHS

Alterations of IGF-1, Complement C3 and Superoxide Dismutase in Patients with Moderate-to-severe Obstructive Sleep Apnea Hypopnea Syndrome.

Contribution of Obstructive Sleep Apnea Syndrome to the Development of Abnormal of Glucose Metabolism

Independent relationship between sleep apnea-specific hypoxic burden and glucolipid metabolism disorder: a cross-sectional study

The latest research progress on the relationship between obstructive sleep apnea–hypopnea syndrome and metabolic syndrome

Correlation between cognitive impairment and serum markers in patients with obstructive sleep apnea–hypopnea syndrome

Metabolomic profiles predict clinical severity in patients with obstructive sleep apnea-hypopnea syndrome

Study about the change of lipid metabolism in patients of obstructive sleep apneahypopnea syndrome

Paired Study on Glucose Metabolism in Obstructive Sleep Apnea Syndrome Patients with Normal Glucose Tolerance

Abnormal Cerebral Blood Flow and Volumetric Brain Morphometry in Patients With Obstructive Sleep Apnea

Research on the Association Between Obstructive Sleep Apnea Hypopnea Syndrome Complicated With Coronary Heart Disease and Inflammatory Factors, Glycolipid Metabolism, Obesity, and Insulin Resistance

[Factors Influencing Glucose Metabolism in Young Obese Subjects with Obstructive Sleep Apnea Hypopnea Syndrome].

Relationships Between Cardiometabolic Disorders and Obstructive Sleep Apnea: Implications for Cardiovascular Disease Risk

Chronic Intermittent Hypoxia in Patients with OSA

Independent Relationships Between Cardinal Features of Obstructive Sleep Apnea and Glycometabolism: a Cross-Sectional Study.

Altered Salivary Microbiota in Patients with Obstructive Sleep Apnea Comorbid Hypertension

Sleep Apnea and Disorders of Glucose Metabolism

Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome

Metabolic consequences of sleep-disordered breathing

Metabolomics and Microbiome Profiling As Biomarkers in Obstructive Sleep Apnoea: a Comprehensive Review

Metabolomics Profiling for Obstructive Sleep Apnea and Simple Snorers